Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis

J.P. Smedema*, G. Ainslie, H.J.G.M. Crijns

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Citations (Web of Science)

Abstract

Sarcoidosis is a relatively rare inflammatory condition which potentially carries high morbidity and substantial mortality. Due to the fact that it does not subject patients to ionizing radiation, has high temporal, spatial and contrast resolutions, cardiovascular magnetic resonance imaging (CMR) has become an important diagnostic and prognostic modality in the evaluation for cardiac involvement in this condition. This review provides relevant dinical and pathophysiological background on cardiac sarcoidosis, whilst detailing the role of CMR imaging in the diagnosis, and management of this condition. (C) 2020 The Author(s). Published by Elsevier Inc.
Original languageEnglish
Pages (from-to)271-307
Number of pages37
JournalProgress in Cardiovascular Diseases
Volume63
Issue number3
DOIs
Publication statusPublished - 1 May 2020

Keywords

  • cardiovascular magnetic resonance
  • corticosteroid-therapy
  • delayed enhancement
  • diagnosis
  • dilated cardiomyopathy
  • heart failure
  • hypertrophic cardiomyopathy
  • late gadolinium enhancement
  • myocardial inflammation
  • positron-emission-tomography
  • prognosis
  • prognostic value
  • risk stratification
  • sarcoidosis
  • term-follow-up
  • ventricular dysfunction
  • ventricular tachycardia
  • Prognosis
  • Cardiovascular magnetic resonance
  • Late gadolinium enhancement
  • PROGNOSTIC VALUE
  • Risk stratification
  • Diagnosis
  • Heart failure
  • Sarcoidosis
  • Ventricular tachycardia
  • DILATED CARDIOMYOPATHY
  • LATE GADOLINIUM ENHANCEMENT
  • POSITRON-EMISSION-TOMOGRAPHY
  • HYPERTROPHIC CARDIOMYOPATHY
  • DELAYED ENHANCEMENT
  • CORTICOSTEROID-THERAPY
  • TERM-FOLLOW-UP
  • MYOCARDIAL INFLAMMATION
  • VENTRICULAR DYSFUNCTION

Cite this